|
Address: |
Building no.3, Business Centre, Academic City, Dubai, UAE
|
| |
|
| Tel: |
+971-2 6179430-32
|
| Fax: |
+971-2-6332256
|
| Email: |
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
|
| Website: |
www.biocon.com
|
NeoBiocon is a new joint venture company between Biocon Limited, a global leading bio-technology company and Neopharma, a leading UAE-based pharmaceutical manufacturing company.
Combining Biocon’s knowledge base and cutting edge technology and Neopharma’s manufacturing prowess and local expertise, NeoBiocon is set to provide specialty bio-pharmaceuticals products. It is an initiative in the GCC region to provide access to world class biopharmaceuticals and niche products.
NeoBiocon is committed to developing a range of products for debilitating diseases in cardiology, diabetology and oncology segments, which represent the fastest growing class of drugs in the GCC pharmaceutical market. The company will be targeting innovative products, including biotech product offerings such as biological, proprietary/in-licensed products, targeted therapeutics; research based formulations and innovative drug delivery system.
NeoBiocon’s Dubai office will represent the company not only in UAE but also in other GCC countries.
|
